摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-苯基缩水甘油 | 98819-68-2

中文名称
3-苯基缩水甘油
中文别名
((2R,3R)-3-苯基环氧乙烷-2-基)甲醇;(2R,3R)-3-苯基甘油醇
英文名称
(R,R)-3-phenyloxiranemethanol
英文别名
3-phenyl-(2R,3R)-oxiran-2-ylmethanol;((2R,3R)-3-phenyloxiran-2-yl)methanol;[(2R,3R)-3-phenyloxiran-2-yl]methanol
3-苯基缩水甘油化学式
CAS
98819-68-2
化学式
C9H10O2
mdl
MFCD00010838
分子量
150.177
InChiKey
PVALSANGMFRTQM-RKDXNWHRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    49-53 °C
  • 沸点:
    278℃
  • 密度:
    1.182
  • 闪点:
    130℃
  • 稳定性/保质期:
    遵照规定使用和储存,则不会发生分解。

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    32.8
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S26,S36/37/39,S45
  • 危险类别码:
    R40
  • 海关编码:
    2910900090
  • 储存条件:
    存于-20°C阴凉干燥处。

SDS

SDS:9df580fae17d610b5f59ce1f64755960
查看
Name: (2R 3R)-3-Phenyl Glycidol 96% (GC) Material Safety Data Sheet
Synonym: None Known
CAS: 98819-68-2
Section 1 - Chemical Product MSDS Name:(2R 3R)-3-Phenyl Glycidol 96% (GC) Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
98819-68-2 (2R,3R)-3-Phenyl Glycidol 96% unlisted
Hazard Symbols: T C
Risk Phrases: 21/22 34 45 46

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful in contact with skin and if swallowed. Causes burns. May cause cancer. May cause heritable genetic damage.Corrosive.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal damage.
Skin:
Causes skin burns. May cause skin rash (in milder cases), and cold and clammy skin with cyanosis or pale color.
Ingestion:
May cause severe and permanent damage to the digestive tract. Causes gastrointestinal tract burns. May cause perforation of the digestive tract. May cause cardiac disturbances. The toxicological properties of this substance have not been fully investigated. May cause central nervous system effects. May cause systemic effects.
Inhalation:
Causes chemical burns to the respiratory tract. The toxicological properties of this substance have not been fully investigated.
Aspiration may lead to pulmonary edema. May cause cardiac abnormalities. May cause systemic effects. Central nervous system effects, which appear to predominate in acute cases are characterized by abnormal fatigue, memory difficulties and dizziness.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed. Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Containers may explode when heated. Non-combustible, substance itself does not burn but may decompose upon heating to produce corrosive and/or toxic fumes.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to extinguish surrounding fire.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Minimize dust generation and accumulation. Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale. Discard contaminated shoes.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
Deep freeze (below -20C).

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 98819-68-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: very slightly yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H10O2
Molecular Weight: 150.18

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 98819-68-2: RR0511120 LD50/LC50:
Not available.
Carcinogenicity:
(2R,3R)-3-Phenyl Glycidol - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, N.O.S.*
Hazard Class: 8
UN Number: 1759
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T C
Risk Phrases:
R 45 May cause cancer.
R 46 May cause heritable genetic damage.
R 21/22 Harmful in contact with skin and if
swallowed.
R 34 Causes burns.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 98819-68-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 98819-68-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 98819-68-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A


上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    3-苯基缩水甘油ammonium hydroxide三甲基氯硅烷四丁基氯化铵sodium tert-pentoxide 、 sodium carbonate 、 三乙胺红铝 、 sodium hydroxide 作用下, 以 甲醇二氯甲烷甲苯 为溶剂, 反应 9.5h, 生成 泼西汀
    参考文献:
    名称:
    (S,S)-瑞波西汀琥珀酸酯的无尖锐不对称环氧化工艺开发
    摘要:
    甲磺酸瑞波西汀是一种选择性的去甲肾上腺素摄取抑制剂(NRI),目前以消旋体形式销售。正在评估瑞波西汀的(S,S)对映异构体用于神经性疼痛和多种其他适应症的治疗。(S,S)-瑞波西汀通常是通过将外消旋物拆分为(-)-扁桃酸盐而制备的,这是一种固有的低效方法。开发了一种手性合成方法,该方法从肉桂醇的Sharpless不对称环氧化开始,生成(R,R)-苯基缩水甘油。使(R,R)-苯基缩水甘油与2-乙氧基苯酚反应而未分离,得到4通过直接结晶分离。研究了不对称环氧化的关键工艺变量。(R,S)-4到瑞波西汀的转化使外消旋合成与简化和优化的加工条件平行。(S,S)-瑞波西汀游离碱直接转化为琥珀酸盐,无需分离为甲磺酸盐。
    DOI:
    10.1021/op700007g
  • 作为产物:
    描述:
    肉桂醇D-(-)-酒石酸二乙酯 、 titanium(IV)isopropoxide 、 叔丁基过氧化氢 作用下, 以 二氯甲烷正己烷 为溶剂, 反应 48.67h, 以64%的产率得到3-苯基缩水甘油
    参考文献:
    名称:
    环氧化物的金催化活化:在双环缩酮合成中的应用
    摘要:
    介绍了金催化从环氧化物生成二醇等价物及其与 C≡C 键的分子内反应生成双环缩酮。该反应主要涉及丙酮化物的形成,其随后在金催化条件下分子内在炔烃上环化。这种方法可以扩展到制造光学纯的双环缩酮。进行氘掺入实验以确定反应机理。
    DOI:
    10.1002/ejoc.201001214
点击查看最新优质反应信息

文献信息

  • [EN] 3-ARYLOXY/ THIO-2, 3-SUBSTITUTED PROPANAMINES AND THEIR USE IN INHIBITING SEROTONIN AND NOREPINEPHRINE REUPTAKE<br/>[FR] 3-ARYLOXY/THIO-2, 3-SUBSTITUE PROPANAMINES ET LEUR UTILISATION POUR INHIBER LE RECAPTAGE DE LA SEROTONINE ET DE LA NOREPINEPHRINE
    申请人:LILLY CO ELI
    公开号:WO2004043903A1
    公开(公告)日:2004-05-27
    There is provided a compound of formula (I) wherein A is selected from -O- and -S-; X is selected from phenyl optionally substituted with up to 5 substituents each independently selected from halo, C1-C4 alkyl and C1-C4 alkoxy, thienyl optionally substituted with up to 3 substituents each independently selected from halo and C1-C4 alkyl, and C2-C8 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl and C4-C8 cycloalkylalkyl, each of which may be optionally substituted with up to 3 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, -CF3, -CN and -CONH2; Y is selected from phenyl, naphthyl, dihydrobenzothienyl, benzothiazolyl, benzoisothiazolyl, quinolyl, isoquinolyl, naphthyridyl, thienopyridyl, indanyl, 1,3-benzodioxolyl, benzothienyl, indolyl and benzofuranyl, each of which may be optionally substituted with up to 4 or, where possible, up to 5 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, nitro, acetyl, -CF3, -SCF3 and cyano; and when Y is indolyl it may be substituted or further substituted by an N-substituent selected from C1-C4 alkyl; Z is selected from OR3 or F, wherein R3 is selected from H, C1-C6 alkyl and phenyl C1-C6 alkyl; R1 and R2 are each independently H or C1-C4 alkyl; and pharmaceutically acceptable salts thereofwith the proviso that when Y is optionally substituted phenyl or optionally substituted 1,3-benzodioxolyl and Z is OR3 and X is optionally substituted phenyl then A is -S-.
    提供一种化合物,其化学式为(I),其中A从-O-和-S-中选择;X从苯基选项地取代,每个取代基可独立地从卤素、C1-C4烷基和C1-C4烷氧基中选择最多5个取代基,噻吩基选项地取代,每个取代基可独立地从卤素和C1-C4烷基中选择最多3个取代基,以及C2-C8烷基、C2-C8烯基、C3-C8环烷基和C4-C8环烷基烷基,每个基可选地取代,每个取代基可独立地从卤素、C1-C4烷基、C1-C4烷氧基、C1-C4烷基-S(O)n-(其中n为0、1或2)、-CF3、-CN和-CONH2中选择;Y从苯基、萘基、二氢苯并噻吩基、苯并噻唑基、苯并异噻唑基、喹啉基、异喹啉基、萘啉基、噻吩吡啉基、茚基、1,3-苯并二氧杂环戊基、苯并噻吩基、吲哚基和苯并呋喃基中选择,每个基可选地取代,最多可独立地从卤素、C1-C4烷基、C1-C4烷氧基、C1-C4烷基-S(O)n-(其中n为0、1或2)、硝基、乙酰基、-CF3、-SCF3和氰基中选择最多4个或在可能的情况下最多5个取代基;当Y为吲哚基时,它可以被取代或进一步被N-取代基取代,N-取代基从C1-C4烷基中选择;Z从OR3或F中选择,其中R3从H、C1-C6烷基和苯基C1-C6烷基中选择;R1和R2各自独立地为H或C1-C4烷基;以及其药学上可接受的盐,但有一个条件,即当Y为可选地取代的苯基或可选地取代的1,3-苯并二氧杂环戊基,Z为OR3且X为可选地取代的苯基时,A为-S-。
  • Metal-Free Epoxidation of Alkenes with Molecular Oxygen and Benzaldehyde under Visible Light Irradiation
    作者:Akichika Itoh、Norihiro Tada、Hiroaki Okubo、Tsuyoshi Miura
    DOI:10.1055/s-0029-1218271
    日期:2009.11
    A new convenient metal-free oxidation protocol of a wide variety of alkenes with molecular oxygen and benzaldehyde under visible light irradiation of fluorescent lamp afforded their corresponding epoxides in 49―99% yields.
    在荧光灯的可见光照射下,多种烯烃与分子氧和苯甲醛的一种新的方便的无金属氧化方案以 49-99% 的产率提供了相应的环氧化物。
  • New Uses for the Burgess Reagent in Chemical Synthesis: Methods for the Facile and Stereoselective Formation of Sulfamidates, Glycosylamines, and Sulfamides
    作者:K. C. Nicolaou、Scott A. Snyder、Deborah A. Longbottom、Annie Z. Nalbandian、Xianhai Huang
    DOI:10.1002/chem.200400503
    日期:2004.11.19
    Although the Burgess reagent (methoxycarbonylsulfamoyltriethylammonium hydroxide, inner salt) has found significant use in chemical synthesis as a dehydrating agent, almost no work has been directed towards its potential in other synthetic applications. As this article will detail, we have found that the Burgess reagent is remarkably effective at accomplishing a number of non-dehydrative synthetic
    尽管Burgess试剂(甲氧基羰基氨磺酰基三乙铵氢氧化物,内盐)已发现在化学合成中作为脱水剂具有重要用途,但几乎没有工作针对其在其他合成应用中的潜力。正如本文将要详细介绍的那样,我们发现,将Burgess试剂应用于适当的底物上,例如从1,2-二醇或环氧醇,α-和C-形成氨基磺酸盐时,在完成许多非脱水合成任务方面非常有效。来自碳水化合物的β-糖胺和来自1,2-氨基醇的环状磺酰胺 除了描述这些新反应歧管的功能之外,我们还描述了一组替代的Burgess型试剂的构造,这些试剂进一步扩展了这些新反应的范围。
  • A Diacetate Ketone-Catalyzed Asymmetric Epoxidation of Olefins
    作者:Bin Wang、Xin-Yan Wu、O. Andrea Wong、Brian Nettles、Mei-Xin Zhao、Dajun Chen、Yian Shi
    DOI:10.1021/jo900330n
    日期:2009.5.15
    A fructose-derived diacetate ketone has been shown to be an effective catalyst for asymmetric epoxidation. High ee values have been obtained for a variety of trans and trisubstituted olefins including electron-deficient α,β-unsaturated esters as well as certain cis olefins.
    果糖衍生的二乙酸酮已被证明是不对称环氧化的有效催化剂。各种反式和三取代烯烃(包括缺电子 α,β-不饱和酯以及某些顺式烯烃)都获得了高 ee 值。
  • Cyclofunctionalisation of epoxyalcohol derivatives. 1. Delivery of functionalised carbon for stereospecific synthesis of dihydrofurans and dihydroxyacids
    作者:Stuart W. McCombie、Bandarpalle B. Shankar、Ashit K. Ganguly
    DOI:10.1016/s0040-4039(01)84583-4
    日期:——
    E-2-(Phenylsulfonyl)vinyl ethers of 2,3-epoxyalcohols are stereospecifically rearranged to 3-(phenylsulfony])-4-(1-hydroxyalkyl)-4,5-dihydrofurans on treatment with LDA. Oxidation of these compounds or the derived des-sulfonyl compounds provides esters or lactones which correspond to regiospecific delivery of -CO2H or -CH2CO2H to C-2, with inversion.
    在用LDA处理后,将2,3-环氧醇的E-2-(苯磺酰基)乙烯基醚立体有择地重排为3-(苯磺酰基)-4-(1-羟烷基)-4,5-二氢呋喃。这些化合物或衍生的去磺酰基化合物的氧化提供了酯或内酯,其对应于-CO 2 H或-CH 2 CO 2 H向C-2的区域特异性递送,并具有转化作用。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐